Ameritas Investment Partners’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
DM
VPM
VCM
FFM
RI
TCM
Ameritas Investment Partners's COGT Position: Q1 2026 in Review
Ameritas Investment Partners increased its Cogent Biosciences (COGT) stake by 3.8% in Q1 2026, buying an estimated $15.8K and bringing the position to 11,713 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #874.
Ameritas Investment Partners first reported a position in COGT in Q2 2018 and has held it in 24 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.
- Ameritas Investment Partners held 11,713 shares of Cogent Biosciences worth $451K as of Q1 2026.
- Ameritas Investment Partners bought 429 Cogent Biosciences shares in Q1 2026, an estimated $15.8K.
- Cogent Biosciences made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #874 holding.
- Ameritas Investment Partners first reported a position in Cogent Biosciences in Q2 2018 and has held it in 24 quarters since.
- 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.